Literature DB >> 3022924

The role of cAMP in regulating tumour cell growth.

M M Gottesman, R D Fleischmann.   

Abstract

Addition of cAMP to various cultured cell types has a dramatic effect on cell growth. Both positive and negative effects on growth have been demonstrated. Analysis of mutants with altered cAMP dependent protein kinases suggests that tumour cells do not require a functional endogenous cAMP system for normal cell cycling. Whether or not cAMP stimulates or inhibits cell growth depends on the cell type, the oncogene driving its growth, the dose of cAMP and the environment of the cell. The ras gene product does not appear to be a component of the adenylate cyclase system, and no other oncogenes have been shown to use cAMP as a second messenger. However, another class of oncogenes possesses a serine/threonine kinase activity analogous to that of cAMP dependent protein kinase. Several oncogene products and growth factor receptors are phosphorylated on serine residues, suggesting that some oncogene products, such as pp60src may be targets for the action of cAMP. The role of cAMP in tumour cell growth may be to modulate the activity of the oncogenes or their protein targets which control cell growth.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022924

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  15 in total

1.  Influence of cyclic AMP and serum factors upon expression of a retinoid-responsive gene in neuroblastoma cells.

Authors:  A K Hall
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

2.  Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography.

Authors:  F Qing; M J Hayes; C G Rhodes; T Krausz; S W Fountain; M M Burke; T Jones; J M Hughes
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.

Authors:  K J Griffin; L S Kirschner; L Matyakhina; S G Stergiopoulos; A Robinson-White; S M Lenherr; F D Weinberg; E S Claflin; D Batista; I Bourdeau; A Voutetakis; F Sandrini; E M Meoli; A J Bauer; Y S Cho-Chung; S R Bornstein; J A Carney; C A Stratakis
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

Review 4.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

5.  A new site and mechanism of action for the widely used adenylate cyclase inhibitor SQ22,536.

Authors:  Andrew C Emery; Maribeth V Eiden; Lee E Eiden
Journal:  Mol Pharmacol       Date:  2012-10-10       Impact factor: 4.436

Review 6.  Sex hormone-binding globulin: not only a transport protein. What news is around the corner?

Authors:  N Fortunati
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

7.  Increased amount of a 25-kilodalton phosphoprotein after v-mos transfection of CHO cells.

Authors:  J K Mayo; K E Sampson; L D Adams; E R Crumm; S L Kelly; I Abraham
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

8.  Different growth responses to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity.

Authors:  E J Ormerod; I R Hart
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

9.  Differential distribution of protein kinases along the crypt-to-lumen regions of rat colonic epithelium.

Authors:  B Schwartz; G M Fraser; J Levy; Y Sharoni; R Guberman; J Krawiec; S A Lamprecht
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

10.  Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.

Authors:  Y J Bang; S J Kim; D Danielpour; M A O'Reilly; K Y Kim; C E Myers; J B Trepel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.